Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma von Silvani, Antonio, De Simone, Irene, Fregoni, Vittorio, Biagioli, Elena, Marchioni, Enrico, Caroli, Manuela, Salmaggi, Andrea, Pace, Andrea, Torri, Valter, Gaviani, Paola, Quaquarini, Erica, Simonetti, Giorgia, Rulli, Eliana, D’Incalci, Maurizio

Volltext

Targeting the EWS–FLI1 transcription factor in Ewing sarcoma von Tancredi, R., Zambelli, A., DaPrada, G. A., Fregoni, V., Pavesi, L., Riccardi, A., Burdach, S., Grohar, P. J., D’Incalci, M.

Volltext

Asymptomatic versus symptomatic pulmonary embolism in oncologic patients: Does clinical presentation influence outcome? von Piacentini, G, Fregoni, V, Gervaso, L, Sansi, C, Cefalì, M, Pavesi, L, Riccardi, A

Volltext

Is there a role for antithrombotic prophylaxis in oncologic patients who undergo central venous access placement? von Cefalì, M, Fregoni, V, Piacentini, G, Sansi, C, Gervaso, L, Pavesi, L, Riccardi, A

Volltext

Full dose Intraoperative Radiotherapy in the conservative treatment of breast cancer: a single institution experience von Tancredi, R, Pozzo, E, Gervaso, L, Cefalì, M, Battista Ivaldi, G, Fissi, S, Riggi, C, Riccardi, A, Fregoni, V

Volltext

1339 - Asymptomatic versus symptomatic pulmonary embolism in oncologic patients: Does clinical presentation influence outcome? von Piacentini, G., Fregoni, V., Gervaso, L., Sansi, C., Cefalì, M., Pavesi, L., Riccardi, A.

Volltext

1338 - Is there a role for antithrombotic prophylaxis in oncologic patients who undergo central venous access placement? von Cefalì, M., Fregoni, V., Piacentini, G., Sansi, C., Gervaso, L., Pavesi, L., Riccardi, A.

Volltext

OC 29.1 Long-Term Outcomes of COVID-19 Associated Venous Thromboembolism (VTE) von Ageno, W., Antonucci, E., Poli, D., Bucherini, E., Chistolini, A., Fregoni, V., Lerede, T., Pancani, R., Pedrini, S., Pieralli, F., Pignatelli, P., Pizzini, A., Podda, G., Potere, N., Sarti, L., Testa, S., Visonà, A., Palareti, G.

Volltext

P01.067 Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma: the experience of the Italian Association of Neuro-Oncology von Simonetti, G, Silvani, A, Biagioli, E, Botturi, A, Caroli, M, de Simone, I, Fregoni, V, Gaviani, P, Lanza, A, Marchioni, E, Pace, A, Quaquarini, E, Salmaggi, A, D’Incalci, M

Volltext

P161 - Full dose Intraoperative Radiotherapy in the conservative treatment of breast cancer: a single institution experience von Tancredi, R., Pozzo, E., Gervaso, L., Cefalì, M., Battista Ivaldi, G., Fissi, S., Riggi, C., Riccardi, A., Fregoni, V.

Volltext

Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantation von FAGNONI, F. F, LOZZA, L, DA PRADA, G, DELLA CUNA, G. Robustelli, ZIBERA, C, ZAMBELLI, A, GIBELLI, N, OLIVIERO, B, PONCHIO, L, FREGONI, V, PAVESI, L, PEROTTI, C

Volltext

Peritumoral Vascular Invasion as Principal Istological Prognostic Factor in TNBC von Rizzo, G., Fregoni, V., Daprada, G., Pavesi, L., Gallizzi, G., Lorenzetti, I.T., Tancredi, R., Ferraris, E., Pagani, A.

Volltext

Vasculitis and all-trans retinoic acid von Fregoni, V, Pastorini, A, Camerone, G

Volltext

Ex vivo generation and expansion of anti‐tumor cytotoxic T‐cell lines derived from patients or their HLA‐identical sibling von Montagna, Daniela, Schiavo, Roberta, Gibelli, Nadia, Pedrazzoli, Paolo, Tonelli, Roberto, Pagani, Sara, Assirelli, Elisa, Locatelli, Franco, Pession, Andrea, Fregoni, Vittorio, Montini, Elisa, Da Prada, Gian Antonio, Siena, Salvatore, Maccario, Rita

Volltext

Prognostic relevance of serum {beta}2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study von Federico, Massimo, Guglielmi, Cesare, Luminari, Stefano, Mammi, Caterina, Marcheselli, Luigi, Gianelli, Umberto, Maiorana, Antonino, Merli, Francesco, Bellei, Monica, Pozzi, Samantha, Stelitano, Caterina, Lazzaro, Antonio, Gobbi, Paolo G, Baldini, Luca, Bergantini, Stefania, Fregoni, Vittorio, Brugiatelli, Maura

Volltext

Subcutaneous Erythropoietin for Treatment of Refractory Anemia in Hematologic Disorders. Results of a Phase I/II Clinical Trial von Cazzola, Mario, Ponchio, Luisa, Beguin, Yves, Rosti, Vittorio, Bergamaschi, Gaetano, Liberato, Nicola L., Fregoni, Vittorio, Nalli, Giulio, Barosi, Giovanni, Ascari, Edoardo

Volltext

Incidence of Human Cytomegalovirus Infection in Patients with Refractory Solid Tumors Receiving Nonmyeloablative Allogeneic Stem Cell Transplants versus Recipients of Standard SCT... von Zambelli, A., Lilleri, D., Pedrazzoli, P., Peccatori, J., Baldanti, F., Fregoni, V., Ciceri, F., Caldera, D., Renga, M., Colombo, A.A., Alessandrino, E.P., Gerna, G., Da Prada, G.A., Siena, S., Bregni, M.

Volltext

Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Li... von Ferrario, Andrea, Merli, Francesco, Luminari, Stefano, Stelitano, Caterina, Mannina, Donato, Russo, Mario, Mazza, Patrizio, Marcheselli, Luigi, Goldaniga, Maria Cecilia, Federico, Massimo, Baldini, Luca

Volltext

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments] von Cazzola, M, Ponchio, L, Beguin, Y, Rosti, V, Bergamaschi, G, Liberato, NL, Fregoni, V, Nalli, G, Barosi, G, Ascari, E

Volltext

Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantation: Immune... von Fagnoni, F F, Lozza, L, Zibera, C, Zambelli, A, Gibelli, N, Oliviero, B, Ponchio, L, Fregoni, V, Pavesi, L, Perotti, C, Da Prada, G, Robustelli della Cuna, G

Volltext